Is a complete LON/0R2B research report available?

No complete published report is available for lon/0R2B (LON/0R2B) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

lon/0R2B stock profile: metrics, valuation and analysis

Market cap	109.3B
Revenue (ttm)	19B
Net income (ttm)	3B
EPS (ttm)	$4.26
P/E (trailing)	36.1x
P/E (forward)	23.6x
Dividend	$1.06 (0.69%)
Volume	1,383
Beta	0.80

All LON/0R2B indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	59,000
Employees Change	-3,000%
Employees Change Percent	-4.76
Enterprise value	$126.7B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	US2358511028
Last refreshed	2026-09-04
Market cap	$109.3B
Price	$208
Price currency	USD
Rev Per Employee	321,986.64x
Sector	Healthcare
Sector PE	21.67
Sector PE Fwd	13.94
Sic	3826
Symbol	lon/0R2B
Website	https://www.danaher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.77%
EV Earnings	41.81x
EV/EBIT	31.12x
EV/EBITDA	20.48x
EV/FCF	30.63x
EV/Sales	6.81x
FCF yield	3.79%
Forward P/E	23.56x
P/B ratio	2.75x
P/E ratio	36.07x
P/S ratio	5.75x
PE Ratio10 Y	34.19x
PE Ratio3 Y	39.98x
PE Ratio5 Y	36.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.89%
EBITDA Margin	31.98%
FCF margin	22.23%
Gross margin	58.75%
Gross Profit	$11.2B
Gross Profit Growth	2.87%
Gross Profit Growth Q	3.8%
Gross Profit Growth3 Y	2.39%
Gross Profit Growth5 Y	-1.89%
Net Income	$3B
Net Income Growth	17.32%
Net Income Growth Q	56.76%
Net Income Growth Qo Q	-15.45%
Net Income Growth Quarters	4%
Net Income Growth Years	0%
Net Income Growth3 Y	-14%
Net Income Growth5 Y	-5.97%
Pretax Margin	18.97%
Profit Margin	15.95%
Profit Per Employee	$51,350
Profitable Quarters	$55
Profitable Years	14
ROA	3.95
Roa5y	4.66
ROCE	6.52
ROE	7.6
Roe5y	9.78
ROIC	6.44
Roic5y	8.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.27%
Cagr3y	-3.42%
Cagr5y	-6.18%
Div CAGR3	11.46%
Div CAGR5	13.05%
EPS Growth	19.57
EPS Growth Q	59.74
EPS Growth Qo Q	-15.17
EPS Growth Quarters	4
EPS Growth Years	0
EPS Growth3 Y	-12.88
EPS Growth5 Y	-5.6
FCF Growth	12.42%
FCF Growth Q	16.06%
FCF Growth Qo Q	16.59%
FCF Growth3 Y	-9.01%
FCF Growth5 Y	-4.49%
OCF Growth	7.55%
OCF Growth Q	14.65%
OCF Growth Qo Q	16.04%
OCF Growth10 Y	4.58%
OCF Growth3 Y	-7.65%
OCF Growth5 Y	-3.52%
Revenue Growth	4.56x
Revenue Growth Q	5.54x
Revenue Growth Qo Q	5.28x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	2.87x
Revenue Growth5 Y	-1.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.29
Assets	$69.9B
Cash	$3.3B
Current Assets	$9.9B
Current Liabilities	$6B
Debt	$21.1B
Debt EBITDA	$3.34
Debt Equity	$0.53
Debt FCF	$5.1
Equity	$39.8B
Interest Coverage	18.83
Liabilities	$30.1B
Long Term Assets	$60B
Long Term Liabilities	$24.1B
Net Cash	$-17.8B
Net Cash By Market Cap	$-16.28
Net Debt EBITDA	$2.93
Net Debt Equity	$0.45
Net Debt FCF	$4.3
Tangible Book Value	$-12.3B
Tangible Book Value Per Share	$-17.43
WACC	7.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.65
Inventory Turnover	3.48
Net Working Capital	$1.8B
Quick ratio	1.15
Working Capital	$4B
Working Capital Turnover	$4.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.87%
Dividend Growth	22.03%
Dividend Growth Years	9%
Dividend per share	$1.06
Dividend Years	11
Dividend Yield	0.69%
Ex Div Date	2026-06-26
Last Dividend	$0.4
Payout Frequency	Quarterly
Payout Ratio	24.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.26%
200-day SMA	202.9
3Y total return	-9.92%
50-day SMA	201.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-27.31%
All Time High	333.6
All Time High Change	-37.6%
All Time High Date	2021-09-10
All Time Low	93.26
All Time Low Change	123.22%
All Time Low Date	2018-02-09
ATR	10.18
Beta	0.8
Ch YTD	-9.65
High	215
High52	244.5
High52 Date	2026-01-22
High52ch	-14.86%
Low	202
Low52	160
Low52 Date	2026-05-18
Low52ch	30.15%
Ma50ch	3.46%
Price vs 200-day SMA	2.59%
RSI	52.68
RSI Monthly	48.63
RSI Weekly	55.25
Sharpe ratio	0.14x
Sharpe Ratio3y	-0.08x
Sharpe Ratio5y	-0.19x
Sortino ratio	0.4
Sortino Ratio3y	0.09
Sortino Ratio5y	-0.07
Total Return	2.56%
Tr YTD	-9.27
Tr1m	5.93%
Tr1w	-3.17%
Tr3m	18.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	625,865,308%
Net Borrowing	7,289,075,996
Shares Insiders	10.86%
Shares Institutions	83.65%
Shares Qo Q	-0.51%
Shares Yo Y	-1.87%
Short Ratio	1.87

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$3.9B
Adjusted OCF	4,795,647,700
Average Volume	1,309.95x
Bv Per Share	56.6
CAPEX	$-884.5M
Ch1m	5.93
Ch1w	-3.17
Ch1y	2.51
Ch3m	17.96
Ch3y	-21.47
Ch5y	-37.1
Ch6m	0.83
Change	-0.96%
Change From Open	-1.84
Close	210.2
Days Gap	0.89
Depreciation Amortization	1,875,625,391
Dollar Volume	287,899.1
Earnings Date	2026-10-20
EBIT	$4.2B
EBITDA	$6.1B
EPS	$4.26
F Score	5
FCF	$4.1B
FCF EV Yield	3.26x
Financing CF	4,433,969,000
Fiscal Year End	December
Founded	1,969
Goodwill	35,136,666,254
Graham Number	100.40095
Graham Upside	-52.33
Income Tax	$584.1M
Investing CF	-8,392,761,800
Is Primary Listing	0
Last Earnings Date	2026-07-21
Last Report Date	2026-06-26
Lynch Fair Value	$29.2
Lynch Upside	-86.14
Ma150	193.9
Ma150ch	7.34%
Ma20	210.1
Ma20ch	-0.94%
Net CF	1,052,500,150
Next Earnings Date	2026-10-20
Open	212.1
P FCF Ratio	26.42
P FCF Ratio SBC	27.94
P OCF Ratio	21.76
P OCF Ratio SBC	22.78
Payment Date	2026-07-31
Position In Range	47.19
Ppne	5,205,953,525
Price Date	2026-09-03
Price EBITDA	$17.99
Relative Volume	0.99x
Revenue	18,997,211,550x
SBC By Revenue	1.18x
Share Based Comp	224,725,050
Tax By Revenue	3.07x
Tax Rate	16.21%
Tr6m	1.25%
Volume	1,383
Z Score	3.45

LON/0R2B (LON/0R2B)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R2B

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R2B indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0R2B

Frequently asked questions